FOLR1 and ovarian carcinoma: Folate receptor alpha (FRα), overexpressed in 90% of ovarian cancers, has been targeted by second‐generation CAR‐NK92 cells, which exhibited strong cytotoxicity against FRα‐positive ovarian cancer cells [63].